Table 1.
Patient's baseline characteristics
| Carvedilol (n = 80) |
Bisoprolol (n = 45) |
p-value | |
|---|---|---|---|
| Demographics | |||
| Male | 62 (78%) | 34 (76%) | 0.83 |
| Age (years) | 71.0 ± 9.7 | 70.7 ± 10.8 | 0.89 |
| NYHA (mean) | 2.1 ± 0.7 | 2.1 ± 0.6 | 0.90 |
| NYHA Class I | 14 (18%) | 5 (11%) | |
| NYHA Class II | 45 (56%) | 30 (67%) | |
| NYHA Class III | 18 (22%) | 10 (22%) | |
| NYHA Class IV | 3 (4%) | 0 | |
| Diabetic Medications | |||
| Diet | 12 (15%) | 5 (11%) | 0.60 |
| Oral hypoglycaemic | 49 (61%) | 27 (60%) | 1.00 |
| Insulin | 19 (24%) | 13 (29%) | 0.53 |
| Heart Failure Medications | |||
| ACEI | 61 (76%) | 33 (73%) | 0.83 |
| ARB | 24 (30%) | 14 (31%) | 1.00 |
| ACE I and ARB | 9 (11%) | 4 (9%) | 0.77 |
| Spironolactone | 50 (62%) | 26 (58%) | 0.70 |
| Thiazide | 11 (14%) | 9 (20%) | 0.45 |
ACEI = Angiotensin Converting Enzyme Inhibitor, ARB = Angiotensin Receptor Blocker